Follistatin-344 FST-344
OtherResearch chemical WADA · Prohibited (S4.3)
Recombinant follistatin isoform sold for laboratory use; no approval in any market.
Monograph plannedAll content is for general information only — not medical advice, not a dosing or usage recommendation, and not a claim of efficacy. Many substances are not approved as medicines or are prescription-only; whether possession and use are legal depends on the law of your country of residence and is your own responsibility. myPeptides does not sell or supply any substances — it is an information and organization tool. For health questions, consult a licensed physician or pharmacist.
Peptide register
Every peptide covered here, with its mechanism class, legal status and WADA status. This is a status register, not a shop: no suppliers, no doses, no efficacy claims.
Class
Legal status
WADA status
Monograph
11 of 73
5-Amino-1MQ
OtherResearch chemical WADA · Prohibited (S0)
Small-molecule NNMT inhibitor studied preclinically; no registered human trials, no approval.
MonographAdipotide
OtherIn clinical development WADA · Prohibited (S0)
Proapoptotic peptidomimetic; early trial work stopped, no approval and no active development.
MonographAICAR
OtherResearch chemical WADA · Prohibited (S4.4.1)
AMP-activated protein kinase activator trialled in the 1990s; not approved in any market.
MonographFOXO4-DRI
OtherResearch chemical WADA · Prohibited (S0)
D-retro-inverso peptide studied in rodent senescence models; no approval in any market.
MonographGlutathione GSH
OtherSupplement
Endogenous tripeptide antioxidant sold as an oral supplement; injectable forms are unapproved.
Injectable forms hold no marketing authorisation
MonographL-Carnitine
OtherSupplement
Amino acid derivative sold as a supplement; a prescription form exists for carnitine deficiency.
A prescription levocarnitine medicine exists for carnitine deficiency
MonographNAD+
OtherSupplement
Coenzyme sold as an oral supplement; injectable forms hold no marketing authorisation.
Injectable forms hold no marketing authorisation
MonographPNC-27
OtherResearch chemical WADA · Prohibited (S0)
p53-derived peptide studied in cell and animal models only; no approval in any market.
Monograph plannedSLU-PP-332
OtherResearch chemical WADA · Prohibited (S0)
Small-molecule estrogen-related receptor agonist; preclinical only, no approval anywhere.
MonographThymosin Alpha-1 Ta1
OtherPrescription medicine
Thymus-derived 28-amino-acid peptide; approved prescription medicine in Italy, China and others.
Not approved in the US
Monograph plannedTake myPeptides with you
Track doses, plans and progress on your phone — end-to-end encrypted.
This article is for informational purposes only and does not replace medical advice. myPeptides gives no dosing recommendations.